-+ 0.00%
-+ 0.00%
-+ 0.00%

China BlueChemical (SEHK:3983) Stock Price Slides As Margin Pressure Deepens

Simply Wall St·08/20/2026 18:26:42
語音播報

China BlueChemical stock closed at HK$1.995 on Thursday, rounding off a weak few months with the share price down about 19% over 90 days. The market clearly came in cautious. The headline from H1 2026 is that earnings held up better than that mood suggests, with basic earnings per share of ¥0.11 and net income of ¥507.4m on revenue of ¥5.6b.

In the short term, the story is about a fertiliser and chemicals producer under share price pressure. Over the longer run, the more important question is whether current margins and the earnings run rate can support the low P/E and discounted valuation already on offer.

Love that China BlueChemical is still producing earnings but concerned that the share price pressure might be signalling higher risk than you would like. If you want a cleaner mix of resilient balance sheets and ongoing profitability, check out our list of solid balance sheet and fundamentals stocks (434 results).

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs H1 2025): ¥5,619.2m vs. ¥5,850.2m (decline of 3.9%)
  • Net Income Excl. Extra Items (H1 2026 vs H1 2025): ¥507.4m vs. ¥640.6m (decline of 20.8%)
  • Basic EPS (H1 2026 vs H1 2025): ¥0.11 per share vs. ¥0.13895 per share (decline of 20.8%)
  • Net Profit Margin (TTM, latest vs prior year): 7.1% vs. 8.7% (margin compression of 1.6 percentage points)

Prefer clean charts instead of a dense wall of earnings figures and margin data? View China BlueChemical's full financial picture, including an at a glance overview of its valuation, in our company report for China BlueChemical.

SEHK:3983 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
SEHK:3983 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

China BlueChemical earnings and the optimistic view

For investors leaning positive on China BlueChemical, the latest half-year shows the company is still generating solid absolute earnings for a cyclical fertiliser and chemicals producer. Revenue of ¥5.6b and net income of ¥507.4m indicate the integrated platform is profitable through the current soft patch. Net margin over the last twelve months at 7.1% remains in reasonable territory for a heavy industry SOE and is not signaling a broken model. That supports the idea of an essential, cash-generating business rather than a structurally impaired one.

China BlueChemical risks reflected in softer metrics

The bear case also finds support in these numbers. Revenue declined 3.9% year on year and net income excluding extra items fell 20.8%, which confirms earnings pressure. Net margin compressed from 8.7% to 7.1%, pointing to weaker pricing or higher costs in fertilisers and chemicals. The share price has also fallen over 90 days, down about 19%, which signals the market is already cautious. Together, these trends match concerns about cyclicality and margin risk even though the balance of the data still shows a profitable company.

Compare China BlueChemical's ability to stay profitable through this softer patch with how the street is reacting to the recent 19% share price decline, and see whether analysts think the current earnings power justifies a different path from here with the consensus price target analysis for China BlueChemical.

Stay Ahead With Simply Wall St

If the recent 19% pullback and still positive earnings from China BlueChemical have your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for an entry point that suits your plan. Once you own it, use the Portfolio Command Center to cut through noise and focus on the updates that matter most for your holdings. For a broader view, tap into the Community to see how other investors are thinking about opportunities and risks. This way you can spot potential catalysts or warning signs early and keep a step ahead of the market.

Seeking Alternatives Beyond China BlueChemical?

Markets move fast and the next breakout list can shift before the crowd reacts. Scan fresh ideas while information is still under the radar for now and act now.

  • Spot cash generative companies before momentum really starts flying by reviewing a curated 277 high quality undervalued stocks that still look overlooked by much of the market.
  • Ride the shift toward electrification and infrastructure upgrades by checking a focused group of 9 top copper producer stocks that could benefit if demand pressure intensifies.
  • Shift your curiosity toward future computing trends with a hand picked set of 24 quantum computing stocks that many investors have not fully caught up with yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.